About the Journal

About the Journal

Journal of Clinical Ayurveda and Translational Medicine (JCATM)
Publisher: TSI-SORG

The Journal of Clinical Ayurveda and Translational Medicine (JCATM) is an international, peer-reviewed, open-access journal devoted to advancing scientific research and clinical understanding of Ayurveda and integrative medical sciences. The journal serves as a bridge between traditional Ayurvedic wisdom and modern biomedical innovation, emphasizing translational approaches that convert classical Ayurvedic principles into clinically validated therapies.

Our mission is to promote high-quality evidence-based research that enhances the credibility, accessibility, and applicability of Ayurveda in global healthcare systems. JCATM welcomes multidisciplinary submissions that explore the intersection of Ayurveda, phytochemistry, molecular biology, regenerative sciences, pharmacology, and clinical medicine.

Scope of the Journal

JCATM publishes original research articles, systematic reviews, short communications, and case studies in the following areas:

  • Clinical evaluation of Ayurvedic formulations and procedures

  • Translational research linking Ayurveda with modern medical science

  • Drug discovery and standardization of herbal and herbo-mineral preparations

  • Evidence-based complementary and integrative therapies

  • Personalized medicine and genomics in Ayurveda

  • Pharmacovigilance and clinical safety studies

  • Preventive health and wellness models rooted in Ayurvedic principles

Editorial Integrity

JCATM maintains rigorous standards of peer review, ethical publication, and research integrity. All submissions undergo double-blind peer review and must adhere to international ethical guidelines for biomedical research.

The journal encourages collaboration among clinicians, academicians, and scientists to foster innovation and knowledge exchange.

Publisher Information

The journal is published by TSI-SORG — a global academic publishing consortium dedicated to fostering excellence in scholarly communication, scientific innovation, and translational research across medicine, life sciences, and technology.

At a glance

  • Peer review: double-blind, by at least two independent experts. The first decision is typically made within 12 to 14 weeks.
  • Quality assurance: every manuscript is screened for similarity with iThenticate, and ethical standards follow COPE guidance.
  • Access and rights: immediate open access under the CC BY 4.0 licence. Authors retain copyright.
  • Identifiers and preservation: Crossref DOIs are assigned, and content is archived for the long term through the PKP Preservation Network.
  • Costs: an Article Processing Charge applies only after acceptance, tiered by country and article type. Full waivers are available.
  • Contact: editor@tsisorg.com